This price move could indicate a change in the trend, and may be a sell signal for investors. A.I.dvisor found 52 similar cases, and were successful. Based on this data, the odds of success are
a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer